| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.64▼ | 7.93▼ | 7.91▼ | 7.00▲ | 8.31▼ |
| MA10 | 7.82▼ | 7.83▼ | 7.41▲ | 7.54▲ | 10.16▼ |
| MA20 | 7.90▼ | 7.24▲ | 7.12▲ | 8.15▼ | 11.64▼ |
| MA50 | 7.21▲ | 7.05▲ | 7.23▲ | 10.26▼ | N/A |
| MA100 | 7.04▲ | 7.55▲ | 7.99▼ | 11.68▼ | N/A |
| MA200 | 7.32▲ | 8.14▼ | 8.55▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.095▼ | 0.071▲ | 0.139▲ | 0.006▲ | -0.540▼ |
| RSI | 49.451▼ | 55.753▲ | 57.204▲ | 39.210▼ | 35.725▼ |
| STOCH | 11.474▼ | 80.719▲ | 88.858▲ | 22.278 | 9.595▼ |
| WILL %R | -74.101 | -32.934 | -32.164 | -60.570 | -88.297▼ |
| CCI | -116.679▼ | 17.195 | 51.801 | -34.377 | -105.833▼ |
|
Wednesday, November 04, 2026 01:06 PM
Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced that members of the management team will participate in the ...
|
|
Wednesday, September 16, 2026 12:37 PM
Agomab Therapeutics targets fibrotic strictures in Crohn’s disease, aiming to create a new treatment category rather than compete with existing therapies. AGMB's ontunisertib showed promising ...
|
|
Wednesday, September 16, 2026 02:15 AM
Looking for more tickers? Browse the full market events calendar. The most recent corporate event for AgomAb Therapeutics (AGMB) was Morgan Stanley 24th Annual Global Healthcare Conference (Corporate ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 7.09 | 8.15 | 7.005 | 7.635 | 158,411 |
| 05/11/26 | 6.85 | 7.46 | 6.46 | 6.97 | 780,193 |
| 04/11/26 | 7.00 | 7.085 | 6.7601 | 6.85 | 79,984 |
| 03/11/26 | 6.67 | 7.155 | 6.67 | 6.85 | 40,243 |
| 02/11/26 | 7.57 | 8.1108 | 6.52 | 6.72 | 105,632 |
| 30/10/26 | 7.00 | 7.955 | 6.61 | 7.49 | 197,833 |
| 29/10/26 | 7.98 | 8.292 | 7.45 | 7.95 | 575,393 |
| 28/10/26 | 8.37 | 8.37 | 7.70 | 7.96 | 105,583 |
| 27/10/26 | 8.60 | 8.60 | 7.88 | 8.40 | 89,797 |
| 26/10/26 | 9.10 | 9.33 | 8.44 | 8.57 | 73,647 |
|
|
||||
|
|
||||
|
|